Success Metrics

Clinical Success Rate

89.8%

Based on 44 completed trials

Completion Rate

90%(44/49)

Active Trials

7(9%)

Results Posted

34%(15 trials)

Terminated

5(7%)

Phase Distribution

Ph phase_3

14%

Ph phase_1

Ph early_phase_1

Ph not_applicable

30%

Ph phase_2

Ph phase_4

34%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution72 total trials

Early Phase 1First-in-human

2(2.8%)

Phase 1Safety & dosage

7(9.7%)

Phase 2Efficacy & side effects

3(4.2%)

Phase 3Large-scale testing

11(15.3%)

Phase 4Post-market surveillance

26(36.1%)

N/ANon-phased studies

23(31.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

44 of 55 finished

Non-Completion Rate

20.0%

11 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(9)

Completed(44)

Terminated(11)

Other(12)

Detailed Status

Completed44

unknown12

Withdrawn6

Terminated5

Recruiting4

Active, not recruiting3

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

89.8%

Most Advanced

Phase 4

Trials by Phase

Early Phase 12 (2.8%)

Phase 17 (9.7%)

Phase 23 (4.2%)

Phase 311 (15.3%)

Phase 426 (36.1%)

N/A23 (31.9%)

Trials by Status

recruiting45%

terminated57%

completed4458%

active_not_recruiting34%

unknown1216%

withdrawn68%

not_yet_recruiting11%

enrolling_by_invitation11%

Recent Activity

7 active trials

Showing 5 of 76

recruitingphase_4

Staphylococcus Aureus Network Adaptive Platform Trial

NCT05137119

recruitingnot_applicable

Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery

NCT02996656

completednot_applicable

Checklist to Prevent MRSA Surgical Site Infections

NCT02216227

recruitingphase_4

Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study

NCT05447559

completednot_applicable

Prophylaxis Against Surgical Site Infections Using Local as Well as Systemic Antibiotic

NCT07478874

View all 76 trials

Clinical Trials (76)

Showing 20 of 76 trialsScroll for more

NCT05137119Phase 4

Staphylococcus Aureus Network Adaptive Platform Trial

Recruiting

NCT02996656Not Applicable

Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery

Recruiting

NCT02216227Not Applicable

Checklist to Prevent MRSA Surgical Site Infections

Completed

NCT05447559Phase 4

Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study

Recruiting

NCT07478874Not Applicable

Prophylaxis Against Surgical Site Infections Using Local as Well as Systemic Antibiotic

Completed

NCT06567808Phase 4

Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial

Not Yet Recruiting

NCT03283878Phase 4

Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial

Completed

NCT06426836Not Applicable

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

Recruiting

NCT03248063Not Applicable

Non-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus Bacteremia

Completed

NCT04875728Phase 1

The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma

Active Not Recruiting

NCT06055712Phase 4

Antibiotic Prophylaxis in Pediatric Open Fractures

Enrolling By Invitation

NCT07186894

Cefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus Bacteremia

Active Not Recruiting

NCT07111702Not Applicable

Prophylactic Antibiotics in Groin Hernioplasty

Completed

NCT02285140Not Applicable

Prevention of Infections in Cardiac Surgery

Terminated

NCT03402945Phase 4

Prevention of Infections in Cardiac Surgery (PICS) Prevena Study

Completed

NCT03862170Phase 3

Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer

Terminated

NCT03094663Phase 4

Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI)

Completed

NCT04775953Phase 2

DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia

Completed

NCT03261830Phase 4

Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS)

Completed

NCT04319328

Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?

Completed

Drug Details

Intervention Type: DRUG
Total Trials: 76